Literature DB >> 8387006

Clinical features and diagnostic approach in type I tyrosinaemia in an infant with cytomegaly virus infection and bacterial sepsis.

M Wabitsch1, F Pohlandt, D Leupold, R Berger, E Mönch, E Heinze, W Teller.   

Abstract

A severely ill 2-month-old female infant was admitted with meningitis and septicaemia caused by Streptococcus pneumoniae. The patient, who also had an acute cytomegalovirus (CMV) infection, revealed the typical clinical and biochemical characteristics of type I tyrosinaemia (TIT). Clinical evidence of severe hepatocellular damage was shown, but urinary succinylacetone was not detected. The diagnosis of TIT was finally confirmed by decreased activity of fumarylacetoacetase (FAA) in skin fibroblasts from the patient and both parents. Following dietary treatment and after overcoming the bacterial and viral infection, the patient's liver function improved.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8387006     DOI: 10.1007/bf01956746

Source DB:  PubMed          Journal:  Eur J Pediatr        ISSN: 0340-6199            Impact factor:   3.183


  21 in total

Review 1.  Outcome of therapy of hereditary tyrosinemia.

Authors:  S Halvorsen; E A Kvittingen; A Flatmark
Journal:  Acta Paediatr Jpn       Date:  1988-08

2.  Hereditary tyrosinemia. 3. On the differential diagnosis and the lack of effect of early dietary treatment.

Authors:  G Bodegård; J Gentz; B Lindblad; S Lindstedt; R Zetterström
Journal:  Acta Paediatr Scand       Date:  1969-01

3.  Prenatal diagnosis of tyrosinaemia type I by use of stable isotope dilution mass spectrometry.

Authors:  C Jakobs; E A Kvittingen; R Berger; A Haagen; W Kleijer; M Niermeijer
Journal:  Eur J Pediatr       Date:  1985-07       Impact factor: 3.183

4.  The communication of ELISA data from laboratory to clinician.

Authors:  D de Savigny; A Voller
Journal:  J Immunoassay       Date:  1980

5.  Hereditary tyrosinemia and tyrosyluria in a French Canadian geographic isolate.

Authors:  C R Scriver; J Larochelle; M Silverberg
Journal:  Am J Dis Child       Date:  1967-01

6.  Urinary excretion of deuterated metabolites in patients with tyrosinemia type I after oral loading with deuterated L-tyrosine.

Authors:  S K Wadman; M Duran; D Ketting; L Bruinvis; F J van Sprang; R Berger; G P Smit; B Steinmann; J V Leonard; P Divry; J P Farriaux; B Cartigny
Journal:  Clin Chim Acta       Date:  1983-05-30       Impact factor: 3.786

7.  Urinary excretion of succinylacetone and delta-aminolevulinic acid in patients with hereditary tyrosinemia.

Authors:  E Christensen; B B Jacobsen; N Gregersen; H Hjeds; J B Pedersen; N J Brandt; U B Baekmark
Journal:  Clin Chim Acta       Date:  1981-11-11       Impact factor: 3.786

Review 8.  Hereditary tyrosinemia type I--an overview.

Authors:  E A Kvittingen
Journal:  Scand J Clin Lab Invest Suppl       Date:  1986

9.  On the enzymic defects in hereditary tyrosinemia.

Authors:  B Lindblad; S Lindstedt; G Steen
Journal:  Proc Natl Acad Sci U S A       Date:  1977-10       Impact factor: 11.205

10.  Biochemical studies of a patient with hereditary hepatorenal tyrosinemia: evidence of glutathione deficiency.

Authors:  E Stoner; H Starkman; D Wellner; V P Wellner; S Sassa; A B Rifkind; A Grenier; P G Steinherz; A Meister; M I New
Journal:  Pediatr Res       Date:  1984-12       Impact factor: 3.756

View more
  1 in total

1.  Persistent coagulopathy during Streptococcus pneumoniae sepsis and left foot abscess in a previously healthy infant revealed tyrosinemia.

Authors:  Bing Liu; Lingyun Guo; Xue Ning; Gang Liu
Journal:  Pediatr Investig       Date:  2021-10-24
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.